Riskpilot← Back to searchSign inGet full accessABMed Oy
OYDissolvedY-tunnus 2848243-5G C 19Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20172 employees
Revenue 2024
EUR 10K
-91% vs 2023
EBITDA margin
80.4%
+182% vs 2023
Equity ratio
82.9%
Financial strength
Net profit 2024
EUR 6K
+165% vs 2023
| Revenue | EUR 10K | -91% |
| EBITDA | EUR 8K | +182% |
| Net profit | EUR 6K | +165% |
| Total assets | EUR 22K | -30% |
| Equity | EUR 18K | +54% |
| Employees | 2 | — |
Legal name
ABMed Oy
Y-tunnus number
2848243-5
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7. elokuuta 2017
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Ravintolisien markkinointi, valmistuttaminen ja kauppa sekä kaikki muu laillinen liiketoiminta. Yhtiö voi omistaa ja hallita kiinteistöjä, osakkeita ja osuuksia sekä käydä niillä kauppaa.
Address
G C 19
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 31 | 63 | 77 | 109 | 10 |
| Staff expenses | — | — | — | −1 | −0 |
| EBITDA | 3 | 7 | 33 | −10 | 8 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 3 | 7 | 33 | −10 | 8 |
| Net financials | −0 | −0 | −0 | 0 | −0 |
| Profit before tax | 3 | 7 | 33 | −10 | 8 |
| Tax | 0 | −0 | 5 | 0 | 2 |
| Net profit | 3 | 7 | 28 | −10 | 6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17 | 18 | 112 | 31 | 22 |
| Equity | −13 | −6 | 22 | 12 | 18 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 30 | 25 | 90 | 20 | 4 |
| Total debt | 30 | 25 | 90 | 20 | 4 |
EBITDA margin
80.4%
This company
15.8%
Market median
+409% vs market
20202024
Equity ratio
82.9%
This company
38.2%
Market median
+117% vs market
20202024
Return on equity
35.3%
This company
18.4%
Market median
+92% vs market
20202024
Net profit margin
63.4%
This company
8.1%
Market median
+683% vs market
20202024
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2017 | |
| Chairperson | 2017 | |
| Board of Directors | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ABMed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mika Petteri Niukkanen | Board of Directors | 0 companies |
| Pasi Tapani Pengermä | Chairperson | 0 companies |
| Lauri Antero Nurmi | Board of Directors | 0 companies |